TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight

The HER2-positive gastric cancer market is experiencing sustained growth, with over 20 companies developing novel targeted therapies, driven by advances in precision medicine and expanded HER2 testing.

Insights
BACpK   neutral

Mentioned as previous employer of new executive, with no direct commentary about the bank's performance


JHPCY   positive

Developing promising pipeline drug SHR-A1811 in Phase III clinical trials